Platelet Aggregation Devices Market Poised to Capitalize on Rising Demand and Innovation
- ajinkya98
- May 14, 2025
- 2 min read
Platelet Aggregation Devices Market Overview
The global platelet aggregation devices market size was valued at USD 841.61 million in 2024. The market is projected to grow from USD 885.46 million in 2025 to USD 1,422.66 million by 2034, exhibiting a compound annual growth rate (CAGR) of 5.4% during the forecast period.
Market Drivers
The market growth is primarily driven by the rising prevalence of cardiovascular disorders, increasing demand for point-of-care testing, advancements in platelet function testing technologies, and a growing geriatric population. The need for accurate diagnostic tools in surgical settings and for monitoring patients on antiplatelet therapy is also fueling demand.
Market Segmentation
The market is segmented by product, application, end-user, and region.
By Product: Systems, reagents, consumables & accessories
By Application: Research, clinical diagnostics
By End-User: Hospitals, diagnostic laboratories, research institutions, others
By Region: North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Key Players
Prominent companies operating in the global platelet aggregation devices market include:
Abbott Laboratories
Siemens Healthineers
Thermo Fisher Scientific
Roche Diagnostics
Beckman Coulter
PLT Scientific
Bio/Data Corporation
Medtronic
Helena Laboratories
Accumetrics (now part of Siemens Healthineers)
Chrono-Log Corporation
Ortho Clinical Diagnostics
A&D Company
Nihon Kohden
Sysmex Corporation
Conclusion
With continued innovation and an increasing focus on precision diagnostics, the platelet aggregation devices market is expected to see steady growth through 2034. The expanding applications in cardiovascular and hematology testing, along with increasing healthcare investments, further support the market’s long-term potential.
Comments